Premium
Effects of the Binding of Imipramine to Erythrocytes and Plasma Proteins on Its Transport Through the Rat Blood‐Brain Barrier
Author(s) -
Riant P.,
Urien S.,
Albengres E.,
Renouard A.,
Tillement J. P.
Publication year - 1988
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.1988.tb01055.x
Subject(s) - imipramine , blood proteins , albumin , free fraction , orosomucoid , chemistry , in vitro , drug , blood–brain barrier , lipoprotein , plasma protein binding , pharmacology , serum albumin , human brain , pharmacokinetics , chromatography , endocrinology , cholesterol , glycoprotein , biochemistry , central nervous system , medicine , pathology , alternative medicine , psychiatry
Brain extraction of a tricyclic antidepressant, imipramine, was investigated using the carotid injection technique in the rat. The extent to which drug binding to plasma proteins and erythrocytes could inhibit the brain extraction was measured. Equilibrium dialysis showed that imipramine is highly bound to human serum albumin (HSA), α 1 ‐acid glycoprotein (AAG), lipoproteins, and erythrocytes. The free dialyzable drug fraction was inversely related to the protein concentration. Despite this degree of binding, no significant reduction in the brain extraction of the drug was observed in the presence of HSA, lipoprotein, or erythrocytes. Only AAG reduced the brain transport of this drug in a ratio related to the protein concentration. However, the rat brain extraction was higher than expected from the in vitro measurement of the dialyzable fraction. These data indicate that the amount of circulating imipramine available for penetration in brain exceeds widely the dialyzable fraction of the drug as measured in vitro.